TransMedics Group, Inc.

NASDAQ (USD): TransMedics Group, Inc. (TMDX)

Last Price

80.48

Today's Change

-7.88 (8.91%)

Day's Change

80.06 - 88.93

Trading Volume

2,261,494

Overview

Market Cap

2 Billion

Shares Outstanding

33 Million

Avg Volume

1,447,550

Avg Price (50 Days)

126.82

Avg Price (200 Days)

122.42

PE Ratio

91.45

EPS

0.88

Earnings Announcement

24-Feb-2025

Previous Close

88.36

Open

88.93

Day's Range

80.06 - 88.93

Year Range

66.76 - 177.37

Trading Volume

2,299,461

Price Change Highlight

1 Day Change

-8.92%

5 Day Change

-7.42%

1 Month Change

-38.08%

3 Month Change

-52.74%

6 Month Change

-40.35%

Ytd Change

4.79%

1 Year Change

20.57%

3 Year Change

225.30%

5 Year Change

342.44%

10 Year Change

259.93%

Max Change

259.93%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment